Benzyl Bromide → 5-Acetyl-1,3-dibenzyluracil
反応式
[C:1]([C:4]1[C:5](=O)[NH:6][C:7](=[O:10])[NH:8][CH:9]=1)(=[O:3])[CH3:2].[C:12](=[O:15])([O-])[O-].[K+].[K+].[CH2:18](Br)[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1>CN(C=O)C>[C:1]([C:4]1[C:12](=[O:15])[N:8]([CH2:9][C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[C:7](=[O:10])[N:6]([CH2:18][C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[CH:5]=1)(=[O:3])[CH3:2]参加物
実験手順
A suspension of 5-acetyluracil (3.1 g, 20 mmol), and potassium carbonate (6.9 g, 50 mmol) in DMF (75 ml) was stirred for 20 min. Then benzyl bromide (6.0 ml, 50 mmol) was added. The resulting mixture was stirred for 8 h at room temperature. DMF was distilled under vacuum. The residue was purified by column (dichloromethane:methanol 40:1). The appropriate fraction was concentrated and crystallized from ethanol to afford 5.34 g of a white solid. Yield was 79.8%. Mp. 92-93° C. 1HNMR (CDCl3): 8.23 (s, 1H), 7.29-7.49 (m, 10H), 5.17 (s, 2H), 5.01 (s, 2H), 2.62 (s, 3H). 13CNMR (CDCl3): 194.5, 160.7, 151.0, 148.4, 136.2, 134.4, 129.2, 129.0, 128.9, 128.5, 128.2, 127.8, 112.2, 53.4, 44.9, 30.7. FAB-HRMS: [M+H]+ calcd. for C20H19N2O3 335.1396, found 335.1412.
後処理
- stirringThe resulting mixture was stirred for 8 h at room temperature
- distillationDMF was distilled under vacuum
- customThe residue was purified by column (dichloromethane:methanol 40:1)
- concentrationThe appropriate fraction was concentrated
- customcrystallized from ethanol
出典と根拠
- ORDレコード
- ord-8574972df5a543168d5832c78c16e4fc
- 出典データセット
- uspto-grants-2007_07
- 特許番号
- US07250421B2
反応ノート
読み込み中…